Coadministering tdap, flu vaccines safe in pregnancy

Coadministering tdap, flu vaccines safe in pregnancy

(HealthDay)—Coadministering tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) and influenza vaccines appears safe in pregnancy, according to a study published online Oct. 5 in Obstetrics & Gynecology.

Lakshmi Sukumaran, M.D., M.P.H., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues retrospectively studied a cohort of pregnant women (aged 14 to 49 years) in the Vaccine Safety Datalink (from Jan. 1, 2007, to Nov. 15, 2013). Medically attended acute events (fever, any acute reaction) and adverse birth outcomes (preterm delivery, low birth weight, small for gestational age) were compared between women receiving concomitant Tdap and influenza vaccination (8,464 patients) and women receiving sequential vaccination (28,380 patients).

The researchers found that acute adverse events after vaccination were rare and that there was no statistically significant increased risk of fever or any medically attended acute adverse event in pregnant women vaccinated concomitantly versus sequentially. There were no differences in preterm delivery, low-birth-weight, or small-for-gestational-age neonates between women vaccinated concomitantly compared with those vaccinated sequentially in pregnancy when the researchers analyzed women at 20 weeks of gestation or greater at the time of influenza vaccine administration.

"Concomitant administration of Tdap and during was not associated with a higher risk of medically attended adverse acute outcomes or birth outcomes compared with sequential vaccination," the authors write.

Two authors disclosed financial ties to the pharmaceutical industry.

More information: Abstract
Full Text (subscription or payment may be required)
Journal information: Obstetrics & Gynecology

Copyright © 2015 HealthDay. All rights reserved.

Citation: Coadministering tdap, flu vaccines safe in pregnancy (2015, October 14) retrieved 3 December 2022 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

No adverse pregnancy outcomes for Tdap at 32 weeks


Feedback to editors